Publications

Search our bibliography using the filters on the right-hand side.

Displaying 51 through 100 of 264 publications.

Anthony MS, Getahun D, Alabaster AL, Cronkite D, Gatz J, Merchant M, Chiu VY, Armstrong MA, Ritchey ME, Fassett MJ, Schoendorf J, Asiimwe A. Feasibility of assessing breastfeeding status in electronic health records. Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):122. doi: 10.1002/pds.4629

Ritchey ME, Hunter S, Peterson C, Nguyen L, Thomas S, Harding A, Andrews EB, Rothman KJ, Cainzos-Achirica M, Anthony MS. Cardiovascular safety of phentermine and topiramate in a United States claims database. Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):449. doi: 10.1002/pds.4629

Rivero-Ferrer E, Martinez D, Rasouliyan L, Anthony MS, Margulis AV, Perez-Gutthann S. Do ICPE pregnancy abstracts make it to term? Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):241. doi: 10.1002/pds.4629

Krueger WS, Anthony MS, Saltus CW, Margulis AV, Rivero-Ferrer E, Monz B, Hirst C, Wormser D, Andrews E. Evaluating the safety of medication exposures during pregnancy: a case study of study designs and data sources in multiple sclerosis. Drugs Real World Outcomes. 2017 Sep;4(3):139-49. doi: 10.1007/s40801-017-0114-9

Carman WJ, Accortt NA, Anthony MS, Iles J, Enger C. Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use. Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1109-18. doi: 10.1002/pds.4261

Krueger WS, Anthony MS, Saltus CW, Margulis AV, Rivero-Ferrer E, Monz B, Wormser D, Andrews E. Existing databases useful for pregnancy exposure and fetal outcomes research, case study in multiple sclerosis (MS). Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 29, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):403. doi: 10.1002/pds

Anthony M, Calingaert B, McQuay LJ, Andrews E, McGrath L, Rothman KJ, Rivero-Ferrer E. Suicide, suicidal behavior, and mortality rates in patients with psoriasis in England. Presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):475. doi: 10.1002/pds

Ritchey ME, Jonsson Funk M, Anthony M, Noren GN, Thomas S, Dasgupta N. Promises and perils of machine learning: a real-world evidence fable. Presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):460. doi: 10.1002/pds

Krueger WS, Anthony MS, Monz B, Saltus C, Hirst C, Margulis AV, Andrews E. Pregnancy studies assessing drug exposure in populations with multiple sclerosis. Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):334.

Kimball AB, Schenfeld J, Accortt NA, Anthony MS, Rothman KJ, Pariser D. Cohort study of malignancies and hospitalised infectious events in treated and untreated patients with psoriasis and a general population in the United States. Br J Dermatol. 2015 Nov;173(5):1183-90. doi: 10.1111/bjd.14068

Wu JJ, Rowan CG, Bebchuk JD, Anthony MS. Total cholesterol, lipoprotein, and triglyceride levels in tumor necrosis factor inhibitor-treated patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis. Int J Dermatol. 2015 Oct;54(10):e442-5. doi: 10.1111/ijd.12921

Carman WJ, Accortt NA, Zhou L, Sanders L, Anthony MS, Enger C. Performance of an algorithm for identifying pregnancy outcomes in commercial health plan claims data. Poster presented at the 31st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2015. Boston, MA.

Carman WJ, Accortt NA, Zhou L, Sanders LA, Anthony MS, Enger C. Performance of an algorithm for determining dates of conception and pregnancy termination dates using commercial health plan claims data. Poster presented at the 31st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2015. Boston, MA.

Wu JJ, Rowan CG, Bebchuk JD, Anthony MS. Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis. Letter to the editor. J Am Acad Dermatol. 2015 May;72(5):917-9.

Wu JJ, Rowan CG, Bebchuk JD, Anthony MS. No association between TNF inhibitor and methotrexate therapy versus methotrexate in changes in hemoglobin A1C and fasting glucose among psoriasis, psoriatic arthritis, and rheumatoid arthritis patients. J Drugs Dermatol. 2015 Feb;14(2):159-66.

Accortt N, Anthony MS, Schenfeld J, Wheeling T, Hassebroek A, O'Malley CD, Sprafka M. Incidence and prevalence of myasthenia gravis in rheumatoid arthritis patients with and without treatment compared with the general population. Poster presented at the 2014 ACR/ARHP Annual Meeting; November 2014. Boston, MA. [abstract] Arthritis Rheumatol. 2014 Oct; 66(Suppl 1):S895.

Samelson EJ, Miller PD, Christiansen C, Daizedeh NS, Grazette L, Anthony MS, Egbuna O, Wang A, Siddhanti SR, Cheung AM, Franchimont N, Kiel DP. RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk. J Bone Miner Res. 2014 Feb;29(2):450-7. doi: 10.1002/jbmr.2043

Kimball AB, Schenfeld J, Accortt NA, Anthony MS, Rothman KJ, Pariser D. Incidence rates of malignancies and hospitalized infections events in psoriasis patients with or without treatment and a general population in the US: 2005-2009. Br J Dermatol. 2014 Feb;170(2):366-73. doi: 10.1111/bjd.12744.

Wade SW, Strader C, Fitzpatrick LA, Anthony MS, O'Malley CD. Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporosis. 2014;9(1):182. doi: 10.1007/s11657-014-0182-3

Wu J, Wu JA, Xiang A, Rowan C, Poon K, Anthony M. Effect of tumor necrosis factor-alfa inhibitor and methotrexate therapy on total cholesterol, high-density lipoprotein, and low-density lipoprotein in psoriasis/psoriatic arthritis and rheumatoid arthritis patients. Poster presented at the American Academy of Dermatology 71st Annual Meeting; March 2013. [abstract] J Am Acad Dermatol. 2013 Apr; 68(4 Suppl 1):AB199. doi: 10.1016/j.jaad.2012.12.821

Tennis P, Rothman KJ, Bohn RL, Tan H, Zavras A, Laskarides C, Calingaert B, Anthony MS. Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis. Pharmacoepidemiol Drug Saf. 2012 Aug 1;21(8):810-7.

Yong M, Schenfeld J, Anthony M, Pariser D, Kimball AB. Malignancy and infection rates in psoriasis patients with or without treatment and in a general population in the US: 2005 – 2009. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21((Suppl 3)):42.

Yong M, Schenfeld J, Anthony MS, Kimball AB. Incidence rates of malignancies and hospitalized infectious events in psoriasis patients with or without treatment and a general population in the United States: 2005–2009. Poster presented at the American Academy of Dermatology 70th Annual Meeting; March 2012. San Diego, CA. [abstract] J Am Acad Dermatol. 2012 Apr; 66(4):AB6.

Wade SW, Strader C, Fitzpatrick LA, Anthony MS. Sex- and age-specific incidence of non-traumatic fractures in selected industrialized countries. Arch Osteoporosis. 2012;7(1-2):219-27.

Lukert B, Satram-Hoang S, Wade S, Anthony MS, Gao G, Downs R. Physician differences in managing postmenopausal osteoporosis: results from the POSSIBLE US™ treatment registry study. Drugs Aging. 2011 Sep 1;28(9):713-27.

Yong M, Schenfeld J, Creamer K, Shi Y, Aras G, Anthony MS. External comparator data for the observational post-marketing safety surveillance registry of enbrel® (etanercept) for the treatment of psoriasis – a single-arm registry study. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S228.

Cawthon PM, Fox KM, Gandra SR, Delmonico MJ, Chiou CF, Anthony MS, Caserotti P, Kritchevsky SB, Newman AB, Goodpaster BH, Satterfield S, Cummings SR, Harris TB, Health, Aging and Body Composition Study . Clustering of strength, physical function, muscle, and adiposity characteristics and risk of disability in older adults. J Am Geriatr Soc. 2011 May;59(5):781-7. doi: 10.1111/j.1532-5415.2011.03389.x

Tosteson AN, Do TP, Wade SW, Anthony MS, Downs RW. Persistence and switching patterns among women with varied osteoporosis medication histories: 12-month results from POSSIBLE US. Osteoporos Int. 2010 Oct;21(10):1769-80. doi: 10.1007/s00198-009-1133-5

Tennis P, Rothman KJ, Bohn R, Tan H, Anthony MS, Zavras A, Calingaert B. Multiple myeloma and IV bisphosphonate are risk factors for osteonecrosis of the jaw. Poster presented at the 26th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(S1):S313-4.

Kiel DP, Grazette L, Siddhanti S, Daizadeh N, Wang A, Anthony MS, Christiansen C. Effect of denosumab on 3-year progression of aortic calcification in postmenopausal women with osteoporosis at high risk of cardiovascular events. Poster presented at the 37th European Symposium on Calcified Tissues Conference; June 2010. Glasgow, Scotland. [abstract] Bone. 2010 Jun; 47(Suppl 1):S69. doi: 10.1016/j.bone.2010.04.134

Nichols GA, Gandra SR, Chiou CF, Anthony MS, Alexander-Bridges M, Brown JB. Successes and challenges of insulin therapy for type 2 diabetes in a managed-care setting. Curr Med Res Opin. 2010 Jan;26(1):9-15. doi: 10.1185/03007990903417679

Egbuna O, Cheung AM, Siddhanti S, Wang A, Daizadeh N, Anthony MS. Treatment of osteoporosis by RANKL inhibition with denosumab in women at high cardiovascular risk and with renal impairment does not accelerate vascular calcification. J Am Soc Nephrol. 2010;21:640A-1A.

Cawthon PM, Fox KM, Gandra SR, Delmonico MJ, Chiou CF, Anthony MS, Sewall A, Goodpaster B, Satterfield S, Cummings SR, Harris TB, Health, Aging and Body Composition Study . Do muscle mass, muscle density, strength, and physical function similarly influence risk of hospitalization in older adults? J Am Geriatr Soc. 2009 Aug;57(8):1411-9. doi: 10.1111/j.1532-5415.2009.02366.x

Barrett-Connor E, Ensrud K, Tosteson AN, Varon SF, Anthony M, Daizadeh N, Wade S. Design of the POSSIBLE US trade mark study: postmenopausal women's compliance and persistence with osteoporosis medications. Osteoporos Int. 2009 Mar;20(3):463-72. doi: 10.1007/s00198-008-0674-3

Luckert B, Wade S, Anthony MS, Gao G, Downs R. Practice patterns among internists, family practitioners, and gynecologists in management of postmenopausal osteoporosis (PMO): results from POSSIBLE US™. Menopause. 2009;16:1256.

Do T, Wade S, Anthony MS, Wagman RB, Downs RW. Medication switching in postmenopausal women on osteoporosis therapy: six-month findings from the POSSIBLE US™ Study. Poster presented at the 30th Annual Meeting of the American Society for Bone and Mineral Research; August 2008. [abstract] J Bone Miner Res. 2008 Aug 13; 23(S1):S468.

Tosteson ANA, Wade S, Anthony MS, Brancato C, Nichols S, Downs RW. Correlates of osteoporosis treatment persistence for patients new to therapy and patients with recent switches: 6-month results from POSSIBLE US. Poster presented at the 30th Annual Meeting of the American Society for Bone and Mineral Research; August 2008. [abstract] J Bone Miner Res. 2008 Aug; 23(Suppl 1):S468.

Cawthon PM, Fox K, Delmonico M, Chiou CF, Gandra SR, Anthony MS. Lean mass, physical function and risk of hospitalization in healthy older adults. Poster presented at the 2008 American Geriatrics Society Annual Scientific Meeting; April 2008. [abstract] J Am Geriatr Soc. 2008 Apr; 56(S1).

Fox KM, Gandra SR, Baumann RL, Anthony MS, Chiou CF. Physical impairment among individuals with unintentional weight loss. Poster presented at the 2008 American Geriatrics Society Annual Scientific Meeting; April 2008. [abstract] J Am Geriatr Soc. 2008 Apr; 56(S1).

Nichols GA, Gandra SR, Chiou CF, Anthony MS, Alexander-Bridges M, Brown JB. Glycemic control and adverse events after insulin initiation in clinical practice. Poster presented at the 68th Scientific Sessions of the American Diabetes Association; 2008. [abstract] Diabetes. 2008; 57 (Suppl 1).

Adams MR, Anthony MS, Chen H, Clarkson TB. Replacement of dietary soy protein isolate with concentrates of soy 7S or 11S globulin has minimal or no effects on plasma lipoprotein profiles and biomarkers of coronary risk in monkeys. Atherosclerosis. 2008 Jan;196(1):76-80.

Arab L, Jardack P, Anthony MS, Schoeller DA. Validity and feasibility of self administered multiple web-based 24 hour recalls: diet day. FASEB J. 2008.

Strader C, Shinoff CW, Fitzpatrick LA, Anthony MS. Burden of hip and wrist fractures: incidence estimates of non-traumatic fractures in older women in North America, Western Europe, Australia, and Japan. Poster presented at the 29th Annual Meeting of the American Society for Bone and Mineral Research; September 2007. [abstract] J Bone Miner Res. 2007 Sep; 22(Suppl 1):S118.

Shadoan MK, Kavanagh K, Zhang L, Anthony MS, Wagner JD. Addition of medroxyprogesterone acetate to conjugated equine estrogens results in insulin resistance in adipose tissue. Metabolism. 2007 Jun;56(6):830-7.

Anthony MS. Soy and women's health. Nutrition for health: an evidence based approach through diet and supplements. Presented at the University of California Irvine; February 25, 2007. Newport Beach, CA.

Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007 Jan;2(1):89-99.

Appt SE, Clarkson TB, Lees CJ, Anthony MS. Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys. Maturitas. 2006 Sep 20;55(2):187-94.

Anthony MS, Stephenson JJ, Long S, Lin SL. Low prevalence of bisphosphonate therapy among long-term glucocorticoid users. Poster presented at the 28th Annual Meeting of the American Society for Bone and Mineral Research; September 2006. Philadelphia, PA. [abstract] J Bone Miner Res. 2006 Sep; 21(Suppl 1):S281.

Wood CE, Register TC, Franke AA, Anthony MS, Cline JM. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast. Cancer Res. 2006 Jan 15;66(2):1241-9.

Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15(5):308-18.